Semaglutide Overview
Read the focused GLP1Scientist research page for this semaglutide question.
Open researchSEMAGLUTIDE COST
Semaglutide Cost: Prices, Coverage and Access
A semaglutide price found online may refer to a list price, cash price, insurance-adjusted cost, reimbursement pathway, manufacturer offer or a different product entirely.
Video explainer
Understanding the GLP-1 Research Platform
Research analysis
Semaglutide Cost: Prices, Coverage and Access
There is no single semaglutide price. Cost depends on brand, formulation, country, insurance or public reimbursement, pharmacy channel and temporary manufacturer programs. In the United States, NovoCare currently lists Wegovy pill and pen at a manufacturer list price of $1,349.02 per package, while actual out-of-pocket costs can differ materially. NovoCare.
List price is not the same as patient cost
The published manufacturer list price is not what every patient pays. Insurance, discounts and eligibility can materially change out-of-pocket cost. NovoCare.
Current US offers
Self-pay and savings programs vary by formulation, dose, eligibility and expiry and should never be treated as permanent prices.
Generic semaglutide changes the Canadian market
Health Canada authorized Sevmia in June 2026, describing it as Canada's first generic semaglutide injection for weight loss. This establishes new competition but does not itself prove a specific nationwide retail-price reduction. Health Canada.
Why international price comparisons are difficult
Tax, dispensing, reimbursement, negotiated pricing, indication, insurance, patient eligibility, generic entry and supply all affect comparisons.
India pricing
No sufficiently authoritative national retail-price figure was locked for India in the current research cycle, so an unsupported number is omitted.
Unauthorized cheap products are not merely a pricing issue
WHO warns about products obtained through unauthorized or informal channels where identity, purity and strength may not be assured. WHO.
Broader research resources
Separate non-prescription research can be explored through consumer health research resources and consumer product comparison resources. These links do not establish an alternative medical treatment or comparable drug price.
Sources and references
- NovoCare Wegovy current pricing
- Health Canada generic semaglutide announcement
- WHO GLP-1 safety statement
See also the research methodology, corrections policy, medical disclaimer and affiliate disclosure.
Frequently asked questions
Questions about this topic
How much does semaglutide cost?
There is no universal number; current US Wegovy list pricing differs from actual patient cost.
Is Wegovy cheaper with insurance?
It may be for eligible patients, but coverage and out-of-pocket cost depend on the plan and eligibility rules.
Is generic semaglutide available?
Canada authorized Sevmia, a generic semaglutide injection for weight loss, in June 2026.
Why does cost differ between countries?
Regulation, reimbursement, insurance, negotiated prices, competition, supply and product availability differ.
About the author
Research direction by Dr. Rahul Dev
Dr. Rahul Dev is a data scientist, patent attorney, life-sciences researcher and global business strategist with more than 20 years of professional experience. He founded GLP1Scientist to organize complex GLP-1 evidence, regulatory information, market data, patent intelligence and commercial developments into a connected global research platform.
Dr. Rahul Dev is not a physician. GLP1Scientist does not provide diagnosis, prescribing, medical care or individualized treatment recommendations.